NCT07658963

Brief Summary

This study examines whether a newly developed four-session psychosocial treatment program, called the First Step Program, can be delivered in real-world hospital settings to people receiving inpatient care for substance use disorders in Korea, and whether it shows early signs of benefit. The program combines motivational interviewing, acceptance and commitment therapy, and group activities, and is delivered twice a week over about two weeks (four 50-minute sessions). About 20 adults will take part at two psychiatric hospitals. Participants complete brief questionnaires and a short interview about their motivation to change, craving, engagement in valued living, and social support before the program, immediately before and after each session, within one week after the program ends, and again at 1 month and 3 months after completion. After the program, some participants also join a small group discussion (focus group interview) to share their experience of the program. Because this is a small, single-group preliminary (pilot) study without a comparison group, its primary purpose is to assess feasibility, that is, whether the program and the assessment approach work well enough, and to obtain preliminary effect and variability estimates to inform the design of a future large-scale randomized controlled trial.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Jun 2026Dec 2026

First Submitted

Initial submission to the registry

June 9, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 22, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

June 22, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

June 22, 2026

Status Verified

June 1, 2026

Enrollment Period

6 months

First QC Date

June 9, 2026

Last Update Submit

June 15, 2026

Conditions

Keywords

Psychosocial interventionCravingGroup therapyAcceptance and Commitment TherapyMotivation to change

Outcome Measures

Primary Outcomes (2)

  • Feasibility: Program Completion (Retention) Rate

    Proportion of enrolled participants who complete all four sessions of the First Step Program. Feasibility is further characterized by recruitment rate, session attendance, and assessment completion rates.

    From enrollment through the end of the 4-session intervention (approximately 2 weeks)

  • Change in Motivation to Change (URICA-DO)

    Motivation to change (readiness) measured by the Korean version of the University of Rhode Island Change Assessment for Drug Offenders (URICA-DO), a 24-item scale rated from 1 (strongly disagree) to 5 (strongly agree) with four subscales (Precontemplation, Contemplation, Action, Maintenance). A Readiness to Change score is computed as the sum of the mean Contemplation, Action, and Maintenance subscale scores minus the mean Precontemplation subscale score, yielding a range of -2 to 14; higher scores indicate greater readiness to change (better outcome).

    Baseline (within 1 week before program), post-intervention (within 1 week after program), 1 month and 3 months after program completion

Secondary Outcomes (5)

  • Change in Craving (VAS-C)

    Immediately before and immediately after each of the 4 sessions (over approximately 2 weeks); baseline (within 1 week before the program); within 1 week post-intervention; 1 month post-intervention; 3 months post-intervention

  • Change in Engaged Living (Engaged Living Scale, ELS)

    Baseline, post-intervention (within 1 week), 1 month and 3 months after completion

  • Change in Social Support (2-Way Social Support Scale)

    Baseline, post-intervention (within 1 week), 1 month and 3 months after completion

  • Change in Drug Use and Treatment Service Utilization

    Baseline, post-intervention (within 1 week), 1 month and 3 months after completion

  • Program Acceptability (Focus Group Interview)

    Within 1 week after program completion

Other Outcomes (3)

  • Stage of Change Rating per Session

    Immediately after each of the 4 sessions (over approximately 2 weeks)

  • Session Satisfaction

    Immediately after each of the 4 sessions

  • Treatment Fidelity (Adherence Rate)

    Immediately after each of the 4 sessions

Study Arms (1)

First Step Program

EXPERIMENTAL

All participants receive the First Step Program, a four-session group-based psychosocial treatment delivered twice weekly (50 minutes per session) over approximately two weeks. The program integrates motivational interviewing, acceptance and commitment therapy, and group therapy, covering values clarification, functional analysis of substance use, ambivalence and recovery-supporting relationships, and a personalized recovery plan.

Behavioral: First Step Program

Interventions

Four 50-minute group sessions delivered twice weekly over approximately two weeks. Session 1: treatment, choice, and personal values. Session 2: understanding the function of substance use and exploring alternative behaviors. Session 3: addressing ambivalence and recovery-supporting relationships. Session 4: charting a recovery direction and declaring a personal recovery plan. Core techniques are motivational interviewing, acceptance and commitment therapy, and group therapy.

First Step Program

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 19 to 65 years who can understand the study purpose and procedures and provide written informed consent
  • Currently hospitalized (inpatient)
  • Able to communicate and complete questionnaires in Korean
  • Physically able to participate in program activities
  • Has completed detoxification treatment
  • Meets indication thresholds: DAST-10 score \>= 2, URICA-DO precontemplation or contemplation stage, and \>= 2 DSM-5 criteria

You may not qualify if:

  • Cognitive impairment that precludes communication
  • Physical conditions that preclude program participation (e.g., musculoskeletal disorder, severe cardiopulmonary disease)
  • Acute psychotic symptoms or risk of self-harm or harm to others
  • At risk of disrupting group activities such that focus group participation is not feasible
  • Individuals who are inmates or incarcerated at screening are not enrolled; participants who become incarcerated after enrollment are withdrawn

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Daegu Daedong Hospital

Daegu, South Korea

Location

Incheon Chamsarang Hospital

Incheon, South Korea

Location

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Hae Kook Lee, MD, PhD

    The Catholic University of Korea

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hae Kook Lee, MD, PhD

CONTACT

Hae-Ryoung Chun, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single-arm pre-post study with follow-up; all participants receive the First Step Program.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 9, 2026

First Posted

June 22, 2026

Study Start

June 22, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

June 22, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

This is a small, single-group pilot study involving sensitive data from patients with substance use disorders. Given the limited sample size and re-identification risk, individual participant data will not be shared. Only de-identified, aggregated results will be reported.

Locations